PT2951172T - Derivados de piridina como inibidores de rock leves - Google Patents

Derivados de piridina como inibidores de rock leves

Info

Publication number
PT2951172T
PT2951172T PT147045322T PT14704532T PT2951172T PT 2951172 T PT2951172 T PT 2951172T PT 147045322 T PT147045322 T PT 147045322T PT 14704532 T PT14704532 T PT 14704532T PT 2951172 T PT2951172 T PT 2951172T
Authority
PT
Portugal
Prior art keywords
pyridine derivatives
soft rock
rock inhibitors
inhibitors
soft
Prior art date
Application number
PT147045322T
Other languages
English (en)
Inventor
Boland Sandro
Bourin Arnaud
Defert Olivier
Leysen Dirk
Original Assignee
Redx Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201303494A external-priority patent/GB201303494D0/en
Application filed by Redx Pharma Plc filed Critical Redx Pharma Plc
Publication of PT2951172T publication Critical patent/PT2951172T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/01Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having one nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT147045322T 2013-01-29 2014-01-27 Derivados de piridina como inibidores de rock leves PT2951172T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13153094 2013-01-29
GB201303494A GB201303494D0 (en) 2013-02-27 2013-02-27 Novel soft rock inhibitors

Publications (1)

Publication Number Publication Date
PT2951172T true PT2951172T (pt) 2017-07-12

Family

ID=50112877

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147045322T PT2951172T (pt) 2013-01-29 2014-01-27 Derivados de piridina como inibidores de rock leves

Country Status (24)

Country Link
US (2) US9682963B2 (pt)
EP (1) EP2951172B8 (pt)
KR (1) KR102275616B1 (pt)
CN (1) CN105026387B (pt)
AU (1) AU2014211580B2 (pt)
BR (1) BR112015018168B1 (pt)
CA (1) CA2898674C (pt)
CY (1) CY1119227T1 (pt)
DK (1) DK2951172T3 (pt)
EA (1) EA029653B1 (pt)
ES (1) ES2629762T3 (pt)
HR (1) HRP20170940T1 (pt)
HU (1) HUE033962T2 (pt)
IL (1) IL240363B (pt)
LT (1) LT2951172T (pt)
MX (1) MX367818B (pt)
NZ (1) NZ711424A (pt)
PL (1) PL2951172T3 (pt)
PT (1) PT2951172T (pt)
RS (1) RS56089B1 (pt)
SG (1) SG11201505867PA (pt)
SI (1) SI2951172T1 (pt)
SM (1) SMT201700317T1 (pt)
WO (1) WO2014118133A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
AR110401A1 (es) 2016-12-21 2019-03-27 Chiesi Farm Spa Derivados dihidropirimidina bicíclica-carboxamida como inhibidores de rho-quinasa
ES2866152T3 (es) 2017-01-30 2021-10-19 Chiesi Farm Spa Derivados de tirosina amida como inhibidores de la Rho-quinasa
US11542256B2 (en) 2017-09-03 2023-01-03 Angion Biomedica Corp. Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
MA50074A (fr) 2017-09-07 2021-04-28 Chiesi Farm Spa Dérivés d'analogues de tyrosine en tant qu'inhibiteurs de rho-kinase
MA51283A (fr) 2017-12-18 2021-05-26 Chiesi Farm Spa Dérivés de tyrosine en tant qu'inhibiteurs de kinase rho
MA51284A (fr) 2017-12-18 2021-05-26 Chiesi Farm Spa Dérivés d'oxadiazole en tant qu'inhibiteurs de kinase rho
AR113947A1 (es) 2017-12-18 2020-07-01 Chiesi Farm Spa Derivados de azaindol como inhibidores de rho-quinasa
PL3759109T3 (pl) 2018-02-26 2024-03-04 Gilead Sciences, Inc. Podstawione związki pirolizyny jako inhibitory replikacji hbv
AR114926A1 (es) 2018-06-13 2020-10-28 Chiesi Farm Spa Derivados de azaindol como inhibidores de rho-quinasa
TW202019923A (zh) 2018-07-16 2020-06-01 義大利商吉斯藥品公司 作為Rho-激酶抑制劑之酪胺酸醯胺衍生物
CN110917352A (zh) * 2019-10-22 2020-03-27 天津医科大学肿瘤医院 Rock抑制剂在肿瘤免疫治疗中的新用法
CA3164134A1 (en) 2019-12-06 2021-06-10 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
JP2023552901A (ja) 2020-12-15 2023-12-19 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Rhoキナーゼ阻害剤としてのジヒドロフロピリジン誘導体
WO2022128853A1 (en) 2020-12-15 2022-06-23 Chiesi Farmaceutici S.P.A. Dihydrofuropyridine derivatives as rho- kinase inhibitors
ES3041795T3 (en) 2020-12-15 2025-11-14 Chiesi Farm Spa Dihydrofuropyridine derivatives as rho- kinase inhibitors
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
WO2023110700A1 (en) 2021-12-13 2023-06-22 Chiesi Farmaceutici S.P.A. Dihydrofuropyridine derivatives as rho-kinase inhibitors
AU2023336823A1 (en) 2022-09-08 2025-02-20 Redx Pharma Limited Solid forms of a rock inhibitor
GB202403179D0 (en) 2024-03-05 2024-04-17 Redx Pharma Plc Method of making kinase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
CN101248046A (zh) * 2005-07-11 2008-08-20 德福根有限公司 作为激酶抑制剂的酰胺衍生物
BRPI0617548A2 (pt) * 2005-10-13 2017-10-03 Devgen Nv Inibidores da quinase
EP2542528B1 (en) 2010-03-02 2013-06-19 Amakem NV Heterocyclic amides as rock inhibitors
GB201114854D0 (en) 2011-08-29 2011-10-12 Amakem Nv Novel rock inhibitors
BR112014004545A2 (pt) * 2011-08-31 2017-04-04 Amakem Nv inibidores leves de rock

Also Published As

Publication number Publication date
HRP20170940T1 (hr) 2017-09-22
ES2629762T3 (es) 2017-08-14
US9850234B2 (en) 2017-12-26
IL240363A0 (en) 2015-09-24
BR112015018168A2 (pt) 2017-07-18
EP2951172B1 (en) 2017-03-29
KR20150114519A (ko) 2015-10-12
US20150361072A1 (en) 2015-12-17
RS56089B1 (sr) 2017-10-31
BR112015018168B1 (pt) 2023-04-11
NZ711424A (en) 2020-03-27
AU2014211580A1 (en) 2015-09-17
CN105026387B (zh) 2018-06-08
HUE033962T2 (en) 2018-01-29
EP2951172B8 (en) 2017-08-02
EP2951172A1 (en) 2015-12-09
SG11201505867PA (en) 2015-08-28
MX367818B (es) 2019-09-09
EA029653B1 (ru) 2018-04-30
WO2014118133A1 (en) 2014-08-07
IL240363B (en) 2018-10-31
KR102275616B1 (ko) 2021-07-09
LT2951172T (lt) 2017-07-25
CA2898674C (en) 2021-01-26
US20170247357A1 (en) 2017-08-31
CA2898674A1 (en) 2014-08-07
SI2951172T1 (sl) 2017-08-31
EA201591371A1 (ru) 2015-12-30
US9682963B2 (en) 2017-06-20
CN105026387A (zh) 2015-11-04
AU2014211580B2 (en) 2018-05-10
CY1119227T1 (el) 2018-02-14
MX2015009674A (es) 2016-03-21
SMT201700317T1 (it) 2017-09-07
DK2951172T3 (en) 2017-07-17
PL2951172T3 (pl) 2018-03-30
HK1215706A1 (zh) 2016-09-09

Similar Documents

Publication Publication Date Title
IL240363B (en) Pyridine derivatives as gentle rock inhibitors
IL245660B (en) History of aminopyridines as tam family kinase inhibitors
IL238391A (en) Rock inhibitors
IL240496A0 (en) New derivatives of pyridine
GB2534272B (en) Rotationally-independent wellbore ranging
IL240327A0 (en) New pyrazole derivatives
IL245443A0 (en) Disubstituted pyridine derivatives are useful as gsk–3 inhibitors
ZA201507657B (en) Pyridin-4-yl derivatives
ZA201508968B (en) Imidazo-triazine derivatives as pde10 inhibitors
PL2970232T3 (pl) Podstawione pochodne pirydyny użyteczne jako inhibitory kinazy c-FMS
PL3027594T3 (pl) Pochodne 2-benzoilaminobenzamidu jako inhibitory bcl-3
GB201303494D0 (en) Novel soft rock inhibitors
GB201302248D0 (en) Reduced Length Rock Drill